2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse

2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse Join us for a cutting-edge My Cancer Haven expert roundtable discussion as we explore the complexities of managing multiple myeloma after the third relapse. Learn how experts approach treatment selection and toxicity management while staying at the forefront of new advancements. 🔍 Key Topics Covered: ✅ Strategies for selecting treatment and managing associated toxicities. ✅ Bi-specific therapies: Their evolving role and potential for community practice. ✅ The future of prophylaxis: Making advanced care feasible for broader adoption. ✅ Addressing infections: Comparing BCMA bi-specifics with GPRC5D bi-specifics. This session is an invaluable resource for healthcare professionals navigating the challenges of advanced multiple myeloma. 🎥 Watch now to stay informed about the latest innovations and expert perspectives! 💬 Don’t forget to like, comment, and share this video to help others in the multiple myeloma community. #MultipleMyeloma #RelapseTreatment #BiSpecifics #ToxicityManagement #InfectionPrevention #MyCancerHaven